Recap: Clearside Biomedical Q2 Earnings



Clearside Biomedical CLSD reported its Q2 earnings results on Tuesday, August 9, 2022.

Here's what investors need to know about the announcement.


Clearside Biomedical reported in-line EPS of $-0.13 versus an estimate of $-0.13.

Revenue was down $396 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.05 which was followed by a 6.21% drop in the share price the next day.

Here's a look at Clearside Biomedical's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.08 0.16 -0.08 -0.12
EPS Actual -0.13 0.31 -0.08 -0.11
Revenue Estimate 2.87M 17.77M 2.58M 690K
Revenue Actual 347K 25.69M 3.07M 780K

To track all earnings releases for Clearside Biomedical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!